Phoenix S&T Nets $500K from Southeast Pennsylvania Greenhouse | GenomeWeb
NEW YORK (GenomeWeb News) – Biomolecular analysis and proteomics company Phoenix S&T has received a $500,000 investment from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania.
 
BioAdvance said today that it has provided the Chester, Pa.-based company with the funding as one of three firms it has newly invested in with a total of $1.5 million.
 
PST has patented injection molded nanospray devices used in biomolecular analysis for proteomics and clinical diagnostics applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.